Trials / Recruiting
RecruitingNCT07244640
Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
Clinical Study on Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The objective of this observational study is to investigate whether non-invasive fundus retinal detection technology can be used for the early diagnosis of parkinson's disease (PD). It aims to answer the following primary questions: the sensitivity and specificity of non-invasive fundus retinal detection technology in the early diagnosis of PD; and whether this technology offers advantages over dopamine transporter positron emission tomography (DAT-PET), a conventional screening method for PD. The researchers will analyze the diagnostic performance of this technology for early-stage PD patients among cohorts including early parkinson's disease, parkinson's syndromes, essential tremor patients, and healthy individuals. Furthermore, in PD patients who concurrently undergo DAT-PET imaging, the study will compare the diagnostic value of non-invasive retinal imaging against that of DAT-PET.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | non-invasive fundus retinal detection | functional optical coherence tomography angiography-retinal neurovascular coupling (fOCTA-rNVC) detection technology |
Timeline
- Start date
- 2025-11-01
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2025-11-24
- Last updated
- 2025-11-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07244640. Inclusion in this directory is not an endorsement.